Trial :

COVID-19 vaccine trial

Info :

Needle free, no overnight stays

Age :

18 - 75 years

Trial length :

8 clinic visits

COVID-19 Vaccine Trial (needle free)

In this trial, we are evaluating the safety and tolerability of a new investigational DNA vaccine to protect against SARS CoV-2 virus. As you are aware, this virus has caused an outbreak of an illness called coronavirus disease-19 (called “COVID‑19”) around the world. In this study, it is the first time that this particular vaccine is given to humans.

This study will require 8 clinic visits and 2 telephone calls over a twelve month period.

To be eligible you must:

  • Be a healthy male or healthy female who is not pregnant or who cannot bear children
  • Aged 18-75 (inclusive)

If you meet the criteria for this study and would like more information, register below or call 1800 727 874.

To view the Media release for this trial, please click here.

Client's Goal

The result of employees, over 115 detailers and engineers, all coming together to solve problem before they arise. the teamwork it demonstrates both internally and externally is outstanding.

  • The triple pressures of more regulations outstanding in the creation.
  • The legacy of the financial crisis has meant a few tricky years
  • Now, the triple pressures of more regulations more regulations
  • Outstanding in the creation he triple pressures of more regulations
  • The triple pressures of more regulations outstanding in the creation.

Process

Teamwork

Looking at Things Differently

Structural steel expertise goes
well participating in the creation
of landmark instead.

Holistic Solutions

We Leverage our Experience

Structural steel expertise goes
well participating in the creation
of landmark instead.

Holistic Solutions

Realize Collaborate Genius

Structural steel expertise goes
well participating in the creation
of landmark instead.